Recursion Pharmaceuticals, Inc. (RXRX)

4.205 +0.12 (+2.81%) USD  |  NASDAQ  |  Jan 02, 16:00
4.22 +0.02 (+0.36%) After-Hours: 17:46
More

Recursion Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
iBio, Inc. Upgrade
GT Biopharma, Inc. Upgrade